Skip to content
  •   Liverpool
  •   merseygastronetwork@gmail.com
  • Twitter
MaGNET

MaGNET

Mersey Gastroenterology Team

  • Home
  • About Us
    • About MaGNET
    • Our Team
    • Join Us
    • Constitution
  • Our Projects
    • MaGNET Projects
    • Individual Projects
    • Upcoming MaGNET projects
    • Project Proposal Form
  • Events
  • Contact

Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn’s disease: A multi-centre retrospective cohort study

Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn’s disease: A multi-centre retrospective cohort study

Post navigation

The benefits of anti-TNF drug and antidrug antibody (ADAb) level monitoring in a DGH
Copyright © 2025 MaGNET All rights reserved. Theme: Flash by ThemeGrill. Powered by WordPress